Fisher Asset Management
LXRX icon

Fisher Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Fisher Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-523,394
Closed -$1.2M – 1232
2023
Q2 		$1.2M Sell
523,394
-126,332
-19% -$335K ﹤0.01% 743
2023
Q1 		$1.58M Sell
649,726
-70,517
-10% -$162K ﹤0.01% 690
2022
Q4 		$1.38M Buy
720,243
+114,715
+19% +$244K ﹤0.01% 716
2022
Q3 		$1.45M Hold
605,528
– – ﹤0.01% 623
2022
Q2 		$1.13M Buy
605,528
+237,334
+64% +$453K ﹤0.01% 616
2022
Q1 		$770K Buy
368,194
+197,424
+116% +$547K ﹤0.01% 653
2021
Q4 		$673K Buy
+170,770
New +$829K ﹤0.01% 703

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return